Century Therapeutics Inc. (IPSC) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Century Therapeutics Inc.

    NASDAQ: IPSC · Real-Time Price · USD
    0.51
    0.01 (1.41%)
    At close: Sep 10, 2025, 3:59 PM
    0.51
    0.00%
    After-hours: Sep 10, 2025, 07:38 PM EDT

    Century Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -126.57M -136.67M -130.93M -95.82M
    Depreciation & Amortization
    		 13.3M 13.04M 8.44M 3.75M
    Stock-Based Compensation
    		 12.69M 14.62M 10.67M 4.66M
    Other Working Capital
    		 -7.81M 11.74M 128.73M -949K
    Other Non-Cash Items
    		 -1.15M 11.28M 1.93M 1.21M
    Deferred Income Tax
    		 870K n/a n/a n/a
    Change in Working Capital
    		 -9.28M 9.38M 123.94M -2.8M
    Operating Cash Flow
    		 -110.14M -88.35M 14.05M -89M
    Capital Expenditures
    		 -154K -13.74M -30.6M -44.97M
    Cash Acquisitions
    		 -9.61M n/a -238.22M -30.34M
    Purchase of Investments
    		 -119.55M -209.03M -254M -330.03M
    Sales Maturities Of Investments
    		 176.79M 283.9M 271.48M 76.67M
    Other Investing Acitivies
    		 n/a n/a 238.22M 30.34M
    Investing Cash Flow
    		 47.48M 61.13M -13.13M -298.34M
    Debt Repayment
    		 n/a -10.24M n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a n/a 36.53M
    Financial Cash Flow
    		 74.56M -9.72M 27.16M 417.77M
    Net Cash Flow
    		 11.91M -36.94M 28.08M 30.43M
    Free Cash Flow
    		 -110.29M -102.08M -16.55M -133.97M

    Add to Watchlist